Page last updated: 2024-08-24

goralatide and Complications of Diabetes Mellitus

goralatide has been researched along with Complications of Diabetes Mellitus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kanasaki, K1
Bombardi, C; Castoldi, G; Corradi, B; di Gioia, CR; Leopizzi, M; Mancini, M; Perego, C; Perego, L; Perlini, S; Stella, A; Zerbini, G1

Reviews

1 review(s) available for goralatide and Complications of Diabetes Mellitus

ArticleYear
N-acetyl-seryl-aspartyl-lysyl-proline is a valuable endogenous antifibrotic peptide for kidney fibrosis in diabetes: An update and translational aspects.
    Journal of diabetes investigation, 2020, Volume: 11, Issue:3

    Topics: Animals; Diabetes Complications; Fibrosis; Humans; Kidney; Kidney Diseases; Oligopeptides; Peptidyl-Dipeptidase A; Signal Transduction

2020

Other Studies

1 other study(ies) available for goralatide and Complications of Diabetes Mellitus

ArticleYear
Prevention of myocardial fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats.
    Clinical science (London, England : 1979), 2009, Oct-26, Volume: 118, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomyopathies; Diabetes Complications; Diabetes Mellitus, Experimental; Fibrosis; Heart Ventricles; Hypoglycemic Agents; Insulin; Male; Myocardium; Oligopeptides; Ramipril; Rats; Rats, Sprague-Dawley; Smad Proteins; Transforming Growth Factor beta1

2009
chemdatabank.com